EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Smoothened Agonist Treatment Mitigates Vasogenic Edema, Neuroinflammation, and Neurological Dysfunction Following Traumatic Brain Injury in Mice

Shotaro Michinaga iD, Kenta Takahashi, Yasuhiro Ogawa, Hiroyuki Mizuguchi, Shigeru Hishinuma

The FASEB Journal · 31.10.2025 · 39 (20)

DOI: 10.1096/fj.202502571r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 24.10.2025. Verfasst von Shotaro Michinaga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics, Meiji Pharmaceutical University, Kiyose, Japan. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Smoothened Receptor, Brain Edema, Neuroinflammatory Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Takeda Science Foundation (TSF), Research Foundation for Pharmaceutical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI)—a serious brain damage caused by accidents, falls, and sports—causes vasogenic edema, neuroinflammation, and neurological dysfunction resulting from blood–brain barrier disruption. Sonic hedgehog (Shh), a secretory protein belonging to the hedgehog family, protects cerebrovascular and neuronal function via the patched‐1 (Ptch‐1)–smoothened (Smo)–Gli pathway. In this study, we investigated the effects of Smo agonists (Shh and SAG) and antagonist (Jervine) on vasogenic edema, neuroinflammation, and neurological dysfunction in mice following TBI. Male ddy mice (8 weeks old) were used to minimize the influence of gonadal hormones on the results. A TBI model was established by inflicting a fluid percussion injury (FPI) on mouse cerebrum or cultured cells. Shh expression increased in mouse cerebrums and cultured astrocytes after FPI. Vasogenic edema was assessed by Evans blue extravasation into brain tissue and increased brain water content. Evans blue extravasation and brain water content increased after FPI. Repeated intracerebroventricular administration of recombinant Shh reduced Evans blue extravasation and brain water content in the cerebrum after FPI, whereas treatment with Jervine, an Smo antagonist, aggravated these conditions. Recombinant Shh administration also decreased the expression of inflammatory cytokines and chemokines in the cerebrum after FPI. Notably, repeated intravenous administration of SAG, a small‐molecule Smo agonist, reduced FPI‐induced vasogenic edema and neuroinflammation, and improved neurological dysfunction in mice. Furthermore, SAG treatment increased the expression of vascular protective factors and tight junction proteins. These results suggest that Smo agonists are promising therapeutic agents for TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticSmoothened ReceptorBrain EdemaNeuroinflammatory DiseasesAnimalsMiceMaleHedgehog ProteinsBlood-Brain BarrierAstrocytesCyclohexylaminesThiophenes

Stichwörter der Autor:innen

blood–brain barrierbrain edemaneuroinflammationneurological dysfunctionsmoothenedsonic hedgehogtraumatic brain injury

Substanzen

Smoothened ReceptorSmo protein, mouseHedgehog ProteinsShh protein, mouseSAG compoundCyclohexylaminesThiophenes

Autor:innen und Institutionen

  • Department of Pharmacodynamics, Meiji Pharmaceutical University, Kiyose, Japan.
  • Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan.

ORCID-Profile: Shotaro Michinaga

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Takeda Science Foundation (TSF)
  • Research Foundation for Pharmaceutical Sciences
  • Japan Society for the Promotion of Science

Zitieren

APA

Michinaga, S., Takahashi, K., Ogawa, Y., Mizuguchi, H., & Hishinuma, S. (2025). Smoothened Agonist Treatment Mitigates Vasogenic Edema, Neuroinflammation, and Neurological Dysfunction Following Traumatic Brain Injury in Mice. The FASEB Journal, 39(20). https://doi.org/10.1096/fj.202502571r

Vancouver

Michinaga S, Takahashi K, Ogawa Y, Mizuguchi H, Hishinuma S. Smoothened Agonist Treatment Mitigates Vasogenic Edema, Neuroinflammation, and Neurological Dysfunction Following Traumatic Brain Injury in Mice. The FASEB Journal. 2025;39(20). doi:10.1096/fj.202502571r

BibTeX
@article{Michinaga2025,
  author = {Michinaga, Shotaro and Takahashi, Kenta and Ogawa, Yasuhiro and Mizuguchi, Hiroyuki and Hishinuma, Shigeru},
  title = {Smoothened Agonist Treatment Mitigates Vasogenic Edema, Neuroinflammation, and Neurological Dysfunction Following Traumatic Brain Injury in Mice},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {20},
  doi = {10.1096/fj.202502571r}
}
Kostenlos starten →